Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Alphavirus vectors and vaccination.

Rayner JO, Dryga SA, Kamrud KI.

Rev Med Virol. 2002 Sep-Oct;12(5):279-96. Review.

PMID:
12211042
2.

Non-viral amplification systems for gene transfer: vectors based on alphaviruses.

Smerdou C, Liljeström P.

Curr Opin Mol Ther. 1999 Apr;1(2):244-51. Review.

PMID:
11715947
3.
4.

Therapeutic and prophylactic applications of alphavirus vectors.

Atkins GJ, Fleeton MN, Sheahan BJ.

Expert Rev Mol Med. 2008 Nov 11;10:e33. doi: 10.1017/S1462399408000859. Review.

PMID:
19000329
5.

Alphavirus DNA and particle replicons for vaccines and gene therapy.

Polo JM, Gardner JP, Ji Y, Belli BA, Driver DA, Sherrill S, Perri S, Liu MA, Dubensky TW Jr.

Dev Biol (Basel). 2000;104:181-5. Review.

PMID:
11713818
6.

Alphavirus-based vaccines.

Lundstrom K.

Curr Opin Mol Ther. 2002 Feb;4(1):28-34. Review.

PMID:
11883692
7.

Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs.

Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S.

J Virol. 1993 Nov;67(11):6439-46.

8.

Alphavirus vectors for cancer gene therapy (review).

Yamanaka R.

Int J Oncol. 2004 Apr;24(4):919-23. Review.

PMID:
15010830
9.

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.

Polo JM, Belli BA, Driver DA, Frolov I, Sherrill S, Hariharan MJ, Townsend K, Perri S, Mento SJ, Jolly DJ, Chang SM, Schlesinger S, Dubensky TW Jr.

Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4598-603.

10.

Alphavirus cDNA-based expression vectors: effects of RNA transcription and nuclear export.

Boorsma M, Saudan P, Pfruender H, Bailey JE, Schlesinger S, Renner WA, Bachmann MF.

Biotechnol Bioeng. 2003 Mar 5;81(5):553-62.

PMID:
12514804
11.
12.

Alphavirus vectors: development and potential therapeutic applications.

Schlesinger S.

Expert Opin Biol Ther. 2001 Mar;1(2):177-91. Review.

PMID:
11727528
13.

Alphavirus vectors for cancer therapy.

Quetglas JI, Ruiz-Guillen M, Aranda A, Casales E, Bezunartea J, Smerdou C.

Virus Res. 2010 Nov;153(2):179-96. doi: 10.1016/j.virusres.2010.07.027. Epub 2010 Aug 6. Review.

PMID:
20692305
14.

Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.

Pijlman GP, Suhrbier A, Khromykh AA.

Expert Opin Biol Ther. 2006 Feb;6(2):135-45. Review.

PMID:
16436039
15.

Replicon-based vectors of positive strand RNA viruses.

Khromykh AA.

Curr Opin Mol Ther. 2000 Oct;2(5):555-69. Review.

PMID:
11249758
16.

Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.

Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ.

Vet Immunol Immunopathol. 2009 Oct 15;131(3-4):158-66. doi: 10.1016/j.vetimm.2009.04.003. Epub 2009 Apr 11.

PMID:
19411115
17.

Alphavirus vectors: applications for DNA vaccine production and gene expression.

Lundstrom K.

Intervirology. 2000;43(4-6):247-57. Review.

PMID:
11251380
18.

Evaluation of cis-acting elements in the rubella virus subgenomic RNA that play a role in its translation.

Pappas CL, Tzeng WP, Frey TK.

Arch Virol. 2006 Feb;151(2):327-46. Epub 2005 Sep 20.

PMID:
16172842
19.

Biology and application of alphaviruses in gene therapy.

Lundstrom K.

Gene Ther. 2005 Oct;12 Suppl 1:S92-7. Review.

PMID:
16231060
20.

A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.

Sánchez-Puig JM, Lorenzo MM, Blasco R.

PLoS One. 2013 Oct 9;8(10):e75574. doi: 10.1371/journal.pone.0075574. eCollection 2013.

Supplemental Content

Support Center